Abstract
Background Dental caries (tooth decay) is the world’s most prevalent noncommunicable disease and can lead to pain, infection, and edentulism. Many children with caries lack access to traditional dental services. School-based caries prevention can increase access to care and reduce health inequities. Disruptions in school-based care due to pandemic control policies may result in children losing access to their primary dental care option.
Methods The CariedAway project was a school-based caries prevention program in operation from 2019-2023 in urban schools with a high proportion of low-income, minority students. Program operations were suspended for two years due to the COVID-19 pandemic. We estimated the prevalence of untreated decay, swelling, fistula, and pulpal involvement in participants at baseline and again after restrictions were lifted.
Results 2998 children between the ages of 5 and 13 years were enrolled and received preventive care prior to pandemic shutdowns, and 1398 (47%) completed their first follow-up observation after two years. At baseline, approximately 30% had untreated caries on any dentition, 11% of children presented with evidence of having received preventive dental sealants, and no participants had swelling, fistula, or pulpal involvement. After 24 months, 12% of participants had swelling fistula, or pulpal involvement that was not treated during the pandemic period.
Conclusion There are considerable unmet dental needs in high-risk children that may be further exacerbated by a lack of access to care during disease outbreaks.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT03442309
Clinical Protocols
https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-018-2891-1
Funding Statement
Research reported in this publication was funded through a Patient-Centered Outcomes Research Institute (PCORI) award (PCS-1609-36824). The content is solely the responsibility of the authors and does not necessarily reflect the official views of the funding organization, New York University, or the NYU College of Dentistry.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB approval from the New York School of Medicine Institutional Review Board (#i17-00578)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
The authors report no conflicts of interest.
Major changes in response to review
Data Availability
CariedAway is an active trial. Data requests will be reviewed and may be available upon approval.
